4//SEC Filing
Jones Mitchell Lawrence 4
Accession 0001493152-25-012691
CIK 0001357459other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 9:00 AM ET
Size
15.9 KB
Accession
0001493152-25-012691
Insider Transaction Report
Form 4
Jones Mitchell Lawrence
Chief Medical Officer
Transactions
- Award
Phantom Units
2025-09-04+289,000→ 289,000 total→ Common Stock (289,000 underlying)
Footnotes (3)
- [F1]Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.
- [F2]The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.
- [F3]Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001993292
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 9:00 AM ET
- Size
- 15.9 KB